Video Experimental Relacionado
Updated: Jul 19, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Eficacia de 15 meses de zidovudina oral materna para disminuir la transmisión vertical del VIH-1 en niños africanos
Lancet (London, England)
|January 15, 2000
Resumen
Un régimen corto de zidovudina oral para madres mostró una eficacia del 30% en la prevención de la transmisión del VIH-1 de madre a hijo durante 15 meses en África Occidental. Este estudio comparó la zidovudina con un placebo para evaluar su efectividad.
Área de la Ciencia:
- Salud Pública La salud pública.
- Enfermedades infecciosas Enfermedades infecciosas.
- Los ensayos clínicos son ensayos clínicos.
Sus antecedentes:
- La transmisión de madre a hijo del Virus de Inmunodeficiencia Humana tipo 1 (VIH-1) es una preocupación significativa para la salud mundial.
- La terapia antirretroviral juega un papel crucial en la prevención de la transmisión vertical del VIH-1.
Objetivo del estudio:
- Evaluar la eficacia de un breve régimen de zidovudina oral materna en la prevención de la transmisión del VIH-1 de madre a hijo.
- Para comparar la eficacia de la zidovudina con un placebo en una población de África Occidental.
Principales métodos:
- Se realizó un ensayo aleatorizado, doble ciego, controlado con placebo.
- Las participantes recibieron zidovudina oral o un placebo durante el embarazo y el parto.
- El estado de infección por el VIH-1 del bebé se evaluó a los 15 meses.
Principales resultados:
- La eficacia a los 15 meses del régimen de zidovudina materna en la prevención de la transmisión del VIH-1 se estimó en un 30%.
- El intervalo de confianza para la eficacia fue de 95% CI -2 a 52%, lo que indica una tendencia hacia la prevención, pero con una amplia variabilidad.
Conclusiones:
- Un corto régimen de zidovudina oral materna demuestra una eficacia parcial en la reducción de la transmisión del VIH-1 de madre a hijo en África Occidental.
- Puede ser necesaria más investigación para optimizar los regímenes para una mayor efectividad en diversos entornos.
Videos de Conceptos Relacionados
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...